Karolinska Institute
A3P Biomedical, BioAgilytix Partner to Bring Prostate Cancer Test to US
The test uses protein biomarkers, genetic biomarkers, clinical data, and a proprietary algorithm to predict the risk of aggressive prostate cancer.
Based on the results of the new studies, the Norwegian company is positioning its calprotectin test as an alternative to conventional ELISAs.
Illumina, Genomic Medicine Sweden to Evaluate Sequencing-Based Leukemia Diagnostics
The study will compare whole-genome sequencing and RNA sequencing to conventional diagnostic methods in about 450 acute leukemia patients in Sweden.
Curetis, Karolinska Institute Collaborate to Identify Bacterial Co-Infections in COVID-19 Patients
The institute will use Curetis' Unyvero Hospitalized Pneumonia panel on high-risk patients admitted to the ICU for COVID-19 pneumonia.
The group aims to validate the tool, called OncoWatch, in a study involving nine countries this year.
Nov 9, 2017
Apr 25, 2017